Lataa...
Profile of Baricitinib and Its Potential in the Treatment of Moderate to Severe Atopic Dermatitis: A Short Review on the Emerging Clinical Evidence
Atopic dermatitis (AD) is the most common chronic cutaneous inflammatory disease of childhood, affecting up to 25% of children; its prevalence in adulthood is currently unknown, since studies reported that AD may affect 0.3–14.3% of adult population. In the last decade, the advanced understanding of...
Tallennettuna:
| Julkaisussa: | J Asthma Allergy |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6999549/ https://ncbi.nlm.nih.gov/pubmed/32099414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S206387 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|